The University of Southampton
University of Southampton Institutional Repository

GLI1 confers profound phenotypic changes upon LNCaP prostrate cancer cells that include the acquisition of a hormone independent state

GLI1 confers profound phenotypic changes upon LNCaP prostrate cancer cells that include the acquisition of a hormone independent state
GLI1 confers profound phenotypic changes upon LNCaP prostrate cancer cells that include the acquisition of a hormone independent state
The GLI (GLI1/GLI2) transcription factors have been implicated in the development and progression of prostate cancer although our understanding of how they actually contribute to the biology of these common tumours is limited. We observed that GLI reporter activity was higher in normal (PNT-2) and tumourigenic (DU145 and PC-3) androgen-independent cells compared to androgen-dependent LNCaP prostate cancer cells and, accordingly, GLI mRNA levels were also elevated. Ectopic expression of GLI1 or the constitutively active ?NGLI2 mutant induced a distinct cobblestone-like morphology in LNCaP cells that, regarding the former, correlated with increased GLI2 as well as expression of the basal/stem-like markers CD44, ?1-integrin, ?Np63 and BMI1, and decreased expression of the luminal marker AR (androgen receptor). LNCaP-GLI1 cells were viable in the presence of the AR inhibitor bicalutamide and gene expression profiling revealed that the transcriptome of LNCaP-GLI1 cells was significantly closer to DU145 and PC-3 cells than to control LNCaP-pBP (empty vector) cells, as well as identifying LCN2/NGAL as a highly induced transcript which is associated with hormone independence in breast and prostate cancer. Functionally, LNCaP-GLI1 cells displayed greater clonal growth and were more invasive than control cells but they did not form colonies in soft agar or prostaspheres in suspension suggesting that they do not possess inherent stem cell properties. Moreover, targeted suppression of GLI1 or GLI2 with siRNA did not reverse the transformed phenotype of LNCaP-GLI1 cells nor did double GLI1/GLI2 knockdowns activate AR expression in DU145 or PC-3 cells. As such, early targeting of the GLI oncoproteins may hinder progression to a hormone independent state but a more detailed understanding of the mechanisms that maintain this phenotype is required to determine if their inhibition will enhance the efficacy of anti-hormonal therapy through the induction of a luminal phenotype and increased dependency upon AR function.
1932-6203
e20271-[13pp]
Nadendla, Sandeep K.
7f2d2860-e9dd-4bd8-a010-a9d66f0041c7
Hazan, Allon
fbb498d4-dcdb-4871-a7c6-c911dd634a6b
Ward, Matt
ec99d2ed-f0c9-4549-8bc3-93115ed3dbb3
Harper, Lisa J.
3cfe3ba3-70b0-43c4-9bfc-f19b3023d874
Moutasim, Karwan
af7dd711-f6df-44f7-8c57-052bf15303af
Bianchi, Lucia S.
1c5b27d2-5ee8-4934-8ae9-03e1554aa6ea
Naase, Mahmoud
169254ad-7e97-4d67-b605-63902f896ad8
Ghali, Lucy
1d6c5667-6c4d-4c80-86f9-09539ea7f563
Thomas, Gareth J.
2ff54aa9-a766-416b-91ee-cf1c5be74106
Prowse, David M.
23651d64-21db-481d-b88b-cb0235802a07
Philpott, Michael P.
80fb7bd9-f113-4823-959d-1df78cbc9871
Neill, Graham W.
5fcb7311-bfdb-4fc1-af65-0cdb236d9169
Nadendla, Sandeep K.
7f2d2860-e9dd-4bd8-a010-a9d66f0041c7
Hazan, Allon
fbb498d4-dcdb-4871-a7c6-c911dd634a6b
Ward, Matt
ec99d2ed-f0c9-4549-8bc3-93115ed3dbb3
Harper, Lisa J.
3cfe3ba3-70b0-43c4-9bfc-f19b3023d874
Moutasim, Karwan
af7dd711-f6df-44f7-8c57-052bf15303af
Bianchi, Lucia S.
1c5b27d2-5ee8-4934-8ae9-03e1554aa6ea
Naase, Mahmoud
169254ad-7e97-4d67-b605-63902f896ad8
Ghali, Lucy
1d6c5667-6c4d-4c80-86f9-09539ea7f563
Thomas, Gareth J.
2ff54aa9-a766-416b-91ee-cf1c5be74106
Prowse, David M.
23651d64-21db-481d-b88b-cb0235802a07
Philpott, Michael P.
80fb7bd9-f113-4823-959d-1df78cbc9871
Neill, Graham W.
5fcb7311-bfdb-4fc1-af65-0cdb236d9169

Nadendla, Sandeep K., Hazan, Allon, Ward, Matt, Harper, Lisa J., Moutasim, Karwan, Bianchi, Lucia S., Naase, Mahmoud, Ghali, Lucy, Thomas, Gareth J., Prowse, David M., Philpott, Michael P. and Neill, Graham W. (2011) GLI1 confers profound phenotypic changes upon LNCaP prostrate cancer cells that include the acquisition of a hormone independent state. PLoS ONE, 6 (5), e20271-[13pp]. (doi:10.1371/journal.pone.0020271). (PMID:21633508)

Record type: Article

Abstract

The GLI (GLI1/GLI2) transcription factors have been implicated in the development and progression of prostate cancer although our understanding of how they actually contribute to the biology of these common tumours is limited. We observed that GLI reporter activity was higher in normal (PNT-2) and tumourigenic (DU145 and PC-3) androgen-independent cells compared to androgen-dependent LNCaP prostate cancer cells and, accordingly, GLI mRNA levels were also elevated. Ectopic expression of GLI1 or the constitutively active ?NGLI2 mutant induced a distinct cobblestone-like morphology in LNCaP cells that, regarding the former, correlated with increased GLI2 as well as expression of the basal/stem-like markers CD44, ?1-integrin, ?Np63 and BMI1, and decreased expression of the luminal marker AR (androgen receptor). LNCaP-GLI1 cells were viable in the presence of the AR inhibitor bicalutamide and gene expression profiling revealed that the transcriptome of LNCaP-GLI1 cells was significantly closer to DU145 and PC-3 cells than to control LNCaP-pBP (empty vector) cells, as well as identifying LCN2/NGAL as a highly induced transcript which is associated with hormone independence in breast and prostate cancer. Functionally, LNCaP-GLI1 cells displayed greater clonal growth and were more invasive than control cells but they did not form colonies in soft agar or prostaspheres in suspension suggesting that they do not possess inherent stem cell properties. Moreover, targeted suppression of GLI1 or GLI2 with siRNA did not reverse the transformed phenotype of LNCaP-GLI1 cells nor did double GLI1/GLI2 knockdowns activate AR expression in DU145 or PC-3 cells. As such, early targeting of the GLI oncoproteins may hinder progression to a hormone independent state but a more detailed understanding of the mechanisms that maintain this phenotype is required to determine if their inhibition will enhance the efficacy of anti-hormonal therapy through the induction of a luminal phenotype and increased dependency upon AR function.

Other
fetchObject.action_uri=info_doi%2F10.1371%2Fjournal.pone.0020271&representation=PDF - Version of Record
Available under License Other.
Download (4MB)

More information

Published date: 25 May 2011
Organisations: Cancer Sciences

Identifiers

Local EPrints ID: 339671
URI: http://eprints.soton.ac.uk/id/eprint/339671
ISSN: 1932-6203
PURE UUID: 7f3ab5e0-dce7-476a-8eb2-d2f129b8a985

Catalogue record

Date deposited: 29 May 2012 10:29
Last modified: 14 Mar 2024 11:13

Export record

Altmetrics

Contributors

Author: Sandeep K. Nadendla
Author: Allon Hazan
Author: Matt Ward
Author: Lisa J. Harper
Author: Karwan Moutasim
Author: Lucia S. Bianchi
Author: Mahmoud Naase
Author: Lucy Ghali
Author: David M. Prowse
Author: Michael P. Philpott
Author: Graham W. Neill

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×